ZIOPHARM Oncology Inc. is a biopharmaceutical company engaged in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies.


Updates from The Motley Fool

Latest updates on ZIOPHARM Oncology from Fool.com.


Stock Performance

ZIOP vs. S&P 500 | 2 Year Performance
View Interactive ZIOP Charts
Sponsored by

Key Data Points

Primary metrics and data points about ZIOPHARM Oncology.
Current Price: $5.83
Prev Close: $5.90
Open: $5.90
Bid: $5.53
Ask: $5.90
Day's Range: $5.75 - $6.00
52wk Range: $4.45 - $14.93
Volume: 1,150,080
Avg Vol 2,349,062
Market Cap: $763.08M
P/E (ttm): -4.54
EPS (ttm): -$1.30
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about ZIOPHARM Oncology.
CAPS Rating 2 out of 5
 
124 Outperform
18 Underperform
CAPS All Stars
 
16 Outperform
10 Underperform

How do you think ZIOPHARM Oncology will perform against the market?



You pick for ZIOPHARM Oncology is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Jonathan J. Lewis, CEO

100% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for ZIOPHARM Oncology.

ZIOPHARM Oncology Inc. is a biopharmaceutical company engaged in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers